NDT Advance Access originally published online on October 12, 2005
Nephrology Dialysis Transplantation 2006 21(1):77-83; doi:10.1093/ndt/gfi185
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Original Articles: Clinical Nephrology
The importance of standardization of creatinine in the implementation of guidelines and recommendations for CKD: implications for CKD management programmes
1 Department of Internal Medicine, 2 Department of Clinical Biochemistry, University Hospital Ghent and 3 Department of Social Health, University Ghent, Belgium
Correspondence and offprint requests to: Wim Van Biesen, Renal Division, University Hospital Ghent, De Pintelaan 185, 9000 Ghent, Belgium. Email: wim.vanbiesen{at}ugent.be
Background. In an attempt to reduce late referral and to improve the care of patients with chronic kidney disease (CKD), different organizations have issued guidelines on when to refer patients to the nephrologist. Most suggest referral of patients with a GFR below 60 ml/min/1.73 m2, and demand referral if the GFR is below 30 ml/min/1.73 m2. It is recommended to use the abbreviated MDRD equation to estimate GFR. This formula is, however, sensitive to the creatinine assay methodology. In addition, the impact of the implementation of such guidelines on the nephrology practice has never been evaluated. This study (i) identifies the true burden of CKD in a population and simulates the effects of a 100% implementation of the guidelines on the nephrology work load, and (ii) evaluates the validity of the estimated GFR using the abbreviated MDRD formula when routinely provided.
Methods. Different laboratories (both hospital and private) in our region were asked to report on all the serum creatinine values performed during the first week of December 2004. If patients had more than one determination, only the lowest serum creatinine value was retained. Patients already known to a nephrology unit were not included. GFR was calculated using the abbreviated MDRD, using the serum creatinine as reported by these laboratories, or after correction to the MDRD-standard using different published equations.
Results. 20 108 patients, with a mean age of 53.4±16.2 years, 48% females, had at least one serum creatinine determination in the observation period. According to the K/DOQI CKD classification, 20.2, 1.6 and 0.8% of females and 13.3, 1.6 and 0.6% of males were in stage 3, 4 and 5, respectively, when the abbreviated MDRD formula was used with the serum creatinine value as reported by the laboratories. Important differences in classifications were obtained when the different correction formulae for creatinine were applied. According to the current recommendations, this would lead to a mandatory referral of 1650–2400 CKD stage 4 patients per 100 000 inhabitants and a suggested referral of another 4100–15 360 CKD stage 3 patients per 100 000 inhabitants to a nephrology unit.
Conclusion. Implementation of the current guidelines for referral of CKD patients to nephrologists would lead to an overload of the nephrology care capacities. Large differences in estimated GFRs with different corrections for serum creatinine are observed, resulting in important CKD classification differences. Standardization of serum creatinine assays is mandatory before guidelines, and especially the routine provision of the estimated GFR by the abbreviated MDRD formula, can be implemented in clinical practice.
Keywords: chronic kidney disease; creatinine; end stage renal disease prevention; glomerular filtration; health economics
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  R. Botev, J.-P. Mallie, C. Couchoud, O. Schuck, J.-P. Fauvel, J. F.M. Wetzels, N. Lee, N. G. De Santo, and M. Cirillo Estimating Glomerular Filtration Rate: Cockcroft-Gault and Modification of Diet in Renal Disease Formulas Compared to Renal Inulin Clearance Clin. J. Am. Soc. Nephrol., May 1, 2009; 4(5): 899 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Baer, N. Lameire, and W. Van Biesen Late referral of patients with end-stage renal disease: an in-depth review and suggestions for further actions NDT Plus, April 29, 2009; (2009) sfp050v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Obermayr, C. Temml, G. Gutjahr, A. Kainz, R. Klauser-Braun, R. Fugger, and R. Oberbauer Body mass index modifies the risk of cardiovascular death in proteinuric chronic kidney disease Nephrol. Dial. Transplant., February 24, 2009; (2009) gfp075v1. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. P. Obermayr, C. Temml, G. Gutjahr, M. Knechtelsdorfer, R. Oberbauer, and R. Klauser-Braun Elevated Uric Acid Increases the Risk for Kidney Disease J. Am. Soc. Nephrol., December 1, 2008; 19(12): 2407 - 2413. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. P. Obermayr, C. Temml, M. Knechtelsdorfer, G. Gutjahr, J. Kletzmayr, S. Heiss, A. Ponholzer, S. Madersbacher, R. Oberbauer, and R. Klauser-Braun Predictors of new-onset decline in kidney function in a general middle-european population Nephrol. Dial. Transplant., April 1, 2008; 23(4): 1265 - 1273. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. E. de Jong, M. van der Velde, R. T. Gansevoort, and C. Zoccali Screening for Chronic Kidney Disease: Where Does Europe Go? Clin. J. Am. Soc. Nephrol., March 1, 2008; 3(2): 616 - 623. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Chonchol, M. Cigolini, and G. Targher Association between 25-hydroxyvitamin D deficiency and cardiovascular disease in type 2 diabetic patients with mild kidney dysfunction Nephrol. Dial. Transplant., January 1, 2008; 23(1): 269 - 274. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. M. Parry Use of Single-Value Protein Compensation of the Jaffe Creatinine Assay Contributes to Clinically Significant Inaccuracy in Results Clin. Chem., January 1, 2008; 54(1): 215 - 216. [Full Text] [PDF]
|
|
|
|
|
|
R. Vanholder, N. Meert, E. Schepers, G. Glorieux, A. Argiles, P. Brunet, G. Cohen, T. Drueke, H. Mischak, G. Spasovski, et al. Review on uraemic solutes II Variability in reported concentrations: causes and consequences Nephrol. Dial. Transplant., November 1, 2007; 22(11): 3115 - 3121. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Cerda, M. Cerda, P. Kilcullen, and J. Prendergast In severe acute kidney injury, a higher serum creatinine is paradoxically associated with better patient survival Nephrol. Dial. Transplant., October 1, 2007; 22(10): 2781 - 2784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Zahran, M. Qureshi, and A. Shoker Comparison between creatinine and cystatin C-based GFR equations in renal transplantation Nephrol. Dial. Transplant., September 1, 2007; 22(9): 2659 - 2668. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. J. Hoek, J. C. Korevaar, F. W. Dekker, E. W. Boeschoten, and R. T. Krediet Estimation of residual glomerular filtration rate in dialysis patients from the plasma cystatin C level Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1633 - 1638. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Van Biesen, D. De Bacquer, F. Verbeke, J. Delanghe, N. Lameire, and R. Vanholder The glomerular filtration rate in an apparently healthy population and its relation with cardiovascular mortality during 10 years Eur. Heart J., February 2, 2007; 28(4): 478 - 483. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Van Biesen, R. Vanholder, and N. Lameire Defining Acute Renal Failure: RIFLE and Beyond Clin. J. Am. Soc. Nephrol., November 1, 2006; 1(6): 1314 - 1319. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. L. Schwartz and S. C. Textor Early Referral for Chronic Kidney Disease: Good for Those Who Need It, but Who Are They? Mayo Clin. Proc., November 1, 2006; 81(11): 1420 - 1422. [Full Text] [PDF]
|
|
|
|
 |
|
 J. Traynor, R. Mactier, C. C Geddes, and J. G Fox How to measure renal function in clinical practice. BMJ, October 7, 2006; 333(7571): 733 - 737. [Full Text] [PDF]
|
|
|
|
|
|
G. Vervoort, J. M. T. Klein Gunnewiek, H. L. Willems, and J. F. M. Wetzels Effect of creatinine assay standardization on the performance of Cockcroft-Gault and MDRD formula in predicting GFR Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2998 - 2999. [Full Text] [PDF]
|
|
|
|
|
|
S. Vickery, P. E. Stevens, R. N. Dalton, F. van Lente, and E. J. Lamb Does the ID-MS traceable MDRD equation work and is it suitable for use with compensated Jaffe and enzymatic creatinine assays? Nephrol. Dial. Transplant., September 1, 2006; 21(9): 2439 - 2445. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Jones, P. Roderick, S. Harris, and M. Rogerson Decline in kidney function before and after nephrology referral and the effect on survival in moderate to advanced chronic kidney disease Nephrol. Dial. Transplant., August 1, 2006; 21(8): 2133 - 2143. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Tonelli, F. Sacks, M. Pfeffer, Z.H. Gao, G. Curhan, for the Cholesterol and Recurrent Events (CARE) Tr, P. Rossing, K. Rossing, P. Gaede, O. Pedersen, et al. Serum Phosphate: A Novel Cardiovascular Risk Factor Even in Nonrenal Patients: Relation between Serum Phosphate Level and Cardiovascular Event Rate in People with Coronary Disease. Circulation 112: 2627-2633, 2005 J. Am. Soc. Nephrol., August 1, 2006; 17(8): 2077 - 2085. [Full Text] [PDF]
|
|
|
|
 |
|
 M.S. MacGregor, D.E. Boag, and A. Innes Chronic kidney disease: evolving strategies for detection and management of impaired renal function QJM, June 1, 2006; 99(6): 365 - 375. [Abstract] [Full Text] [PDF]
|
|